NEWS

抄読会論文
  • Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomized, controlled, phase 2b trial.

    2023.01.26 | 抄読会論文
    抄読会要旨 岡林比呂子...
  • Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study

    2023.01.16 | 抄読会論文
    抄読会要旨 猿渡功一...
  • Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

    2023.01.5 | 抄読会論文
    抄読会要旨 冨田 雄介...
  • High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

    2022.11.21 | 抄読会論文
    抄読会要旨 髙木僚...
  • Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective selfcontrolled study

    2022.09.30 | 抄読会論文
    抄読会要旨 今井...
  • Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

    2022.09.29 | 抄読会論文
    抄読会要旨 岡林 ...
  • Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort

    2022.09.29 | 抄読会論文
    9.22+抄読会 穴井...
  • Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

    2022.09.15 | 抄読会論文
    抄読会2022.9.8PDF...
Copyright© 2023 熊本大学大学院生命科学研究部 呼吸器内科学分野 All rights reserved.